FOCL vs NRXS: stock comparison and AI forecast
Edap Tms Sa (FOCL) and Neuraxis, Inc (NRXS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
FOCL Edap Tms Sa
- Market Cap
- $125M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NRXS Neuraxis, Inc
- Market Cap
- $77M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- FOCL is 1.6 times larger than NRXS by market capitalization ($125M against $77M).
- FOCL carries 2.08 times debt per unit of equity, against 0.48 times for NRXS.
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | FOCL | NRXS |
|---|---|---|
| Market Cap | $125M | $77M |
| P/B Ratio | 3.05x | 11.39x |
| EPS | $-0.35 | $-0.92 |
| Book Value/Share | $1.09 | $0.54 |
| Revenue/Share | $1.81 | $0.42 |
Profitability & Margins
| Metric | FOCL | NRXS |
|---|---|---|
| ROE | – | -114.0% |
| ROA | – | -76.8% |
| ROIC | -39.3% | -111.3% |
| Gross Margin | 48.0% | 85.6% |
| Operating Margin | -50.2% | -144.5% |
| Net Margin | – | -144.4% |
| EBT Margin | -61.2% | -144.5% |
| Tax Rate | -0.8% | -0.3% |
Financial Health
| Metric | FOCL | NRXS |
|---|---|---|
| Current Ratio | 2.63x | 3.04x |
| Quick Ratio | 2.40x | 2.95x |
| D/E Ratio | 2.08x | 0.48x |
| Financial Leverage | 3.08x | 1.48x |
| Interest Coverage | -138.9x | -107.3x |
| Working Capital | $67M | $6M |
Cash Flow
| Metric | FOCL | NRXS |
|---|---|---|
| Operating Cash Flow | -$17M | -$6M |
Operational Efficiency
| Metric | FOCL | NRXS |
|---|---|---|
| Asset Turnover | 0.53x | 0.53x |
| Receivables Turnover | 5.8x | 12.3x |
| Inventory Turnover | 3.6x | 2.8x |
| Fixed Assets Turnover | 6.5x | 81.2x |
| Days Sales Outstanding | 64 days | 30 days |
| Days Inventory | 100 days | 132 days |
| Payables Period | – | 376 days |
| Cash Conversion Cycle | – | -215 days |
Income Statement
| Metric | FOCL | NRXS |
|---|---|---|
| Total Revenue | $68M | $5M |
| Operating Income | -$34M | -$8M |
| Net Income | – | -$8M |
| R&D Expense | $11M | $750K |
| SG&A Expense | – | $11M |
| Cost of Goods Sold | $35M | $770K |
Dividend & Shareholder Information
| Metric | FOCL | NRXS |
|---|---|---|
| Shares Outstanding | 38M | 13M |
FOCL vs NRXS: stock comparison and AI forecast
Which is bigger, FOCL or NRXS?
FOCL is 1.6 times larger than NRXS by market capitalization ($125M against $77M).
Which one does Intratio's AI model rank higher, FOCL or NRXS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.